164 related articles for article (PubMed ID: 34235218)
1. Antischistosomal Activity of
Fadladdin YAJ
Biomed Res Int; 2021; 2021():5545331. PubMed ID: 34235218
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
Kovač J; Vargas M; Keiser J
Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
[TBL] [Abstract][Full Text] [Related]
3. Schistosoma haematobium (Egyptian strain): rate of development and effect of praziquantel treatment.
Botros SS; Hammam OA; El-Lakkany NM; El-Din SH; Ebeid FA
J Parasitol; 2008 Apr; 94(2):386-94. PubMed ID: 18564739
[TBL] [Abstract][Full Text] [Related]
4. Effect of praziquantel on the immature stages of Schistosoma haematobium.
Botros S; Pica-Mattoccia L; William S; El-Lakkani N; Cioli D
Int J Parasitol; 2005 Nov; 35(13):1453-7. PubMed ID: 16002073
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone derivative, against Schistosoma haematobium.
Guirguis FR
Arzneimittelforschung; 2003; 53(1):57-61. PubMed ID: 12608016
[TBL] [Abstract][Full Text] [Related]
6. Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
Koehne E; Zander N; Rodi M; Held J; Hoffmann W; Zoleko-Manego R; Ramharter M; Mombo-Ngoma G; Kremsner PG; Kreidenweiss A
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009511. PubMed ID: 34166393
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis.
Alghamdi T; Salem DA; El-Refaei MF
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011426. PubMed ID: 37339146
[TBL] [Abstract][Full Text] [Related]
9. Further assessment of Mirazid as antischistosomal drug in experimental schistosomiasis hematobium.
Ramzy F; Mahmoud S; William S
Pharm Biol; 2010 Jul; 48(7):775-9. PubMed ID: 20645776
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium.
El Ridi R; Aboueldahab M; Tallima H; Salah M; Mahana N; Fawzi S; Mohamed SH; Fahmy OM
Antimicrob Agents Chemother; 2010 Aug; 54(8):3383-9. PubMed ID: 20479203
[TBL] [Abstract][Full Text] [Related]
11. Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study.
Soliman MF; Ibrahim MM
Acta Trop; 2005 Jan; 93(1):1-9. PubMed ID: 15589792
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
13.
Güler E; Özbilgin A; Çavuş İ; Baddal B; Etikan İ; Başer KHC; Şanlıdağ T
Turkiye Parazitol Derg; 2021 Jun; 45(2):101-107. PubMed ID: 34103285
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of artemisinin-naphthoquine phosphate on Schistosoma haematobium stages and the vector Bulinus truncatus.
El-Beshbishi SN; El Bardicy S; Tadros M; Ayoub M; Taman A
Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):320-325. PubMed ID: 30668820
[TBL] [Abstract][Full Text] [Related]
15. Evaluating ancient Egyptian prescriptions today: Anti-inflammatory activity of Ziziphus spina-christi.
Kadioglu O; Jacob S; Bohnert S; Naß J; Saeed ME; Khalid H; Merfort I; Thines E; Pommerening T; Efferth T
Phytomedicine; 2016 Mar; 23(3):293-306. PubMed ID: 26969383
[TBL] [Abstract][Full Text] [Related]
16. Scanning electron microscopy of normal and praziquantel treated S. haematobium worms (Egyptian strain).
Awadalla HN; el Azzouni MZ; Khalil AI; el Mansoury ST
J Egypt Soc Parasitol; 1991 Dec; 21(3):715-22. PubMed ID: 1765683
[TBL] [Abstract][Full Text] [Related]
17. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel.
Ahmed AM; Abbas H; Mansour FA; Gasim GI; Adam I
Parasit Vectors; 2012 Jun; 5():108. PubMed ID: 22676052
[TBL] [Abstract][Full Text] [Related]
20. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
Coles GC; Liang YS; Doenhoff MJ
Emerg Infect Dis; 2001; 7(6):1069-70. PubMed ID: 11747748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
